A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors

Clinical trial NCT07208773 · RECRUITING

Trial details

NCT number: NCT07208773
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Non Small Cell Lung Cancer Small Cell Lung Cancer

Start date: 2025-10-29
Primary completion: 2027-01-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.